Using Biomaterials journal research as prior art

Introduction

Tissue engineering combines cells, scaffolds and biologically active signals to repair or replace tissue. It grew out of academic laboratories and much of its foundational knowledge was published in scientific journals long before it was claimed in patents. One of the leading venues for that literature is the journal Biomaterials (Elsevier), which has published work on scaffolds, hydrogels, bioactive coatings, drug delivery, decellularised matrices, bioprinting and cell-material interactions for decades.

That deep archive makes it a valuable source of prior art when a tissue engineering patent is challenged. This article explains how journal articles qualify as prior art, how to build anticipation and obviousness arguments from them, how to prove publication dates and what pitfalls arise in the procedure of challenging a patent.

This article is general information, not legal advice. The legal framework is described mainly by reference to United States law, with brief comparative notes. Consult a qualified patent attorney for any invalidity or freedom-to-operate opinion.

Why Journal Literature Is Powerful Prior Art in Tissue Engineering

  • Scientists publish first. Academic researchers typically publish methods, compositions and results before or around the time industry partners file patents.
  • Detailed disclosure. Journal articles include materials, concentrations, fabrication steps, characterisation data and in vitro or in vivo results, which often match the limitations in patent claims.
  • Searchable and datable. Articles carry DOIs, volume and issue numbers, received, accepted and online dates and are indexed in large databases.
  • Credibility. Peer-reviewed work is generally regarded as reliable by examiners, administrative judges and courts.
  • Breadth of coverage. Review articles in Biomaterials summarise many prior studies and can supply motivation to combine references and evidence of what a skilled person knew.

Legal Framework

Prior Art Under 35 U.S.C. 102

For applications filed under the America Invents Act (on or after March 16, 2013), a claim is invalid as anticipated if the claimed invention was patented, described in a printed publication, in public use, on sale or otherwise available to the public before the effective filing date, unless an exception applies. The most important exception for academic work is the one-year grace period for disclosures made by the inventor or by others who obtained the subject matter from the inventor. A Biomaterials article authored by the inventors, published within one year before filing, may therefore not count as prior art, while an article by unrelated authors, or published more than a year earlier, may.

Anticipation

Anticipation requires that a single reference disclose every element of the claim, arranged as claimed, in a way that enables a person of ordinary skill to practise the invention. Inherent disclosure can satisfy this rule if the missing feature is necessarily present. Prior art publications are presumed to be enabling and the patentee generally carries the burden of producing evidence to rebut that presumption.

Obviousness Under 35 U.S.C. 103

A claim is invalid as obvious if the differences between the claim and the prior art would have been obvious to a person of ordinary skill. The analysis follows Graham v. John Deere: determine the scope and content of the prior art, the differences between the art and the claims, the level of ordinary skill and objective indicia such as commercial success, long-felt need, failure of others and unexpected results. KSR v. Teleflex rejects rigid application of a teaching-suggestion-motivation test and allows a flexible approach, including combining familiar elements by known methods to achieve predictable results. In unpredictable fields, the question of a reasonable expectation of success is central.

Other Jurisdictions

In Europe, novelty requires that the invention not be part of the state of the art, which includes everything made available to the public before the filing or priority date and inventive step is assessed using the problem-and-solution approach. India applies novelty and inventive step standards under the Patents Act and also considers publication anywhere in the world as prior art. Local grace periods are narrow or absent in many countries, so a journal article by the inventors can be fatal abroad even if it is tolerated in the United States.

What Makes a Journal Article a Printed Publication

A printed publication must be publicly accessible, meaning that interested persons exercising reasonable diligence could locate it. For a Biomaterials article, accessibility is usually straightforward, but the date needs to be established with care.

Date typeMeaningUse as prior art
Received / acceptedDates in the manuscript historyNot the publication date; useful as background only.
Available online (online first)The date the final article or accepted manuscript appeared on the publisher siteOften the earliest public date; verify through the publisher page and DOI record.
Issue / cover dateThe date of the journal issueMay be later than online availability; use the earliest date that is provable.
Indexing dateDate when a database listed the articleWeak evidence; useful only as corroboration.
Library receipt or archive stampEvidence of actual public accessibilityHelpful for older print issues.

If the date is questioned, evidence can include the publisher’s metadata, a declaration from a librarian or publisher representative, archived web copies, database records and the print volume itself. Pre-publication or accepted-manuscript versions are prior art only if they were publicly available, for example in a repository with a known posting date.

Finding the Right Articles

A systematic search strategy increases the strength of an invalidity position.

  1. Parse the claims. Break each claim into elements: material (for example, a particular polymer or ceramic), structure (porosity, fibre diameter, pore size), cell type, growth factor, process step and intended tissue.
  2. Fix the critical date. Identify the effective filing date and the earliest priority date to which each claim is truly entitled.
  3. Search multiple databases. Use ScienceDirect for the journal itself, plus PubMed, Scopus, Web of Science, Google Scholar and patent databases. Search with synonyms, abbreviations and chemical names, such as PLGA, poly(lactic-co-glycolic acid), PCL, gelatin methacryloyl and GelMA.
  4. Use citation chasing. Follow references cited by and citing articles, including review papers in Biomaterials and the inventors’ own earlier publications.
  5. Search by property and method terms. Claims often recite results (for example a compressive modulus range or a degradation time). Search for numerical values and characterisation methods.
  6. Document the search. Record queries, dates and results to show diligence and to support later amendment of the grounds.

Building an Anticipation Case

The most effective anticipation arguments rely on claim charts that map each limitation to specific passages, tables or figures in a single article. For example, a claim to a porous scaffold of a given polymer with a stated pore size and seeded with a stated cell type may be anticipated by a Biomaterials paper that describes the same scaffold, fabricated by a described method and cultured with that cell type.

Anticipation arguments often turn on details. Points to examine include whether the article discloses the claimed ranges or an overlapping value (overlapping ranges are generally treated as at least prima facie obvious and a prior art point within a claimed range can anticipate); whether a combination of features is disclosed together, not in separate embodiments requiring picking and choosing; whether inherent properties, such as degradation profile or mechanical strength, necessarily follow from the described composition; and whether the article enables the invention, taking into account supplemental information and cited methods.

Be careful with a claim chart that relies on an inventor’s declaration, a later paper or additional experiments to show the inherent property. Evidence from after the critical date can sometimes confirm inherency, but it must show that the property necessarily results from the prior art disclosure, not merely that it might.

Building an Obviousness Case

Most tissue engineering patents are challenged on obviousness because claims often combine known elements: a known scaffold material, a known cell source, a known growth factor and a known culture or fabrication process. A strong argument has four components.

  • Primary reference. A Biomaterials article disclosing the closest scaffold, material or approach, ideally with the same intended tissue application.
  • Secondary reference(s). Articles that supply the missing element, such as a surface modification, a crosslinking method or a growth factor delivery system.
  • Reason to combine. Explicit statements in the articles, general knowledge, review statements, a recognised design need or market pressure, or the predictable use of a known technique for its established purpose.
  • Reasonable expectation of success. Experimental results, similar applications in related tissues and the success of comparable modifications show that a skilled person could expect the combination to work.

Tissue engineering is sometimes described as unpredictable and patent owners often argue that results in one cell type, polymer or anatomical site do not transfer to another. Challengers should therefore use references that are as close as possible in material and application and use expert testimony to explain why the differences would not have prevented success.

Anticipating the Patent Owner’s Responses

Patent owner argumentPossible reply
The reference is not enablingPrior art publications are presumed enabling; point to the methods, supplementary data and cited protocols that allow replication.
The reference teaches awayShow that the reference merely expresses a preference or discusses an alternative without discouraging the combination.
Unexpected resultsCompare with the closest prior art, argue that results are not commensurate in scope with the claims and show that the results were predictable from the literature.
Hindsight reconstructionCite explicit reasons in the references and expert evidence of what a skilled person would have known.
The article is not prior artEstablish the publication date and any lack of authorship overlap, or show that the grace-period exception does not apply.
Commercial successShow lack of nexus between sales and the claimed features and the influence of marketing or other factors.

Forums and Procedures

ProcedureBasis for challengeKey features
Inter partes review (IPR)Novelty and obviousness, based only on patents and printed publicationsAvailable after the nine-month period following grant; written, technical, with expert declarations; strict timelines.
Post-grant review (PGR)Any ground of invalidity, including 112 and 101Must be requested within nine months of grant; broader grounds than IPR.
Ex parte reexaminationSubstantial new question of patentability based on patents and printed publicationsExaminer-driven, lower cost, no estoppel for the requester.
District court litigationAny invalidity defence, including public use and salePresumption of validity; clear and convincing evidence standard; juries may be involved.
Opposition or revocation (other offices)Grounds depend on the jurisdiction, commonly novelty, inventive step and sufficiencyTime-limited in many offices, such as nine months from grant at the EPO.

The choice of forum affects evidence. Because IPR and reexamination are limited to patents and printed publications, journal articles are especially well suited to them. In district court, the challenger must overcome the statutory presumption of validity by clear and convincing evidence, though the examiner’s failure to consider a reference can influence how persuasive it seems. Procedural rules, discretionary denial practices and fee structures evolve, so verify them before choosing a strategy.

Practical Checklist for Using Biomaterials Articles as Prior Art

  • Determine the effective filing date for each claim and whether it is entitled to priority.
  • Collect the earliest provable public date for each article, with publisher metadata and, where needed, declarations.
  • Check authorship against the named inventors to evaluate grace-period exceptions.
  • Obtain the full text and supplementary information, not only the abstract.
  • Prepare claim charts with pinpoint citations to pages, paragraphs, figures and tables.
  • Prepare an expert declaration describing the level of skill, the meaning of technical terms and the reasons to combine.
  • Review the file history for statements by the applicant that characterise or distinguish the references.
  • Review the claim construction and consider how the patent owner may narrow terms to avoid the art.
  • Look for related patents, continuations and foreign counterparts for alternative arguments and consistent positions.
  • Preserve copies of every cited item and an organised exhibit list.

Common Pitfalls

  • Citing an article with an issue date later than the critical date without checking for earlier online availability, or conversely citing an online date without proof.
  • Relying on an abstract that does not disclose all the details needed.
  • Mixing embodiments from different parts of an article without showing that the combination is disclosed.
  • Overlooking that a claim has a valid earlier priority date, which may place the article after the critical date.
  • Not accounting for claim construction, which can move the claim away from the cited disclosure.
  • Presenting conclusory expert opinions without factual support.
  • Ignoring supplementary information and cited protocols, which can supply necessary enablement.

Conclusion

The Biomaterials journal archive is an exceptional resource for challenging tissue engineering patents because it records how the field developed in the years before many patent filings. To turn that literature into a persuasive invalidity case, the challenger must establish a reliable publication date, show that the article qualifies as prior art under the correct statute, map every claim element to the disclosure and present a coherent motivation to combine references with a reasonable expectation of success. Careful searching, rigorous claim charts, expert support and a well-chosen forum together give the best chance of success and the same disciplined approach helps patent owners assess the strength of their own claims.

Leave a Reply

Your email address will not be published. Required fields are marked *